Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Daewoong Pharmaceutical Publishes Molecular Mechanism of Bersiporocin as an Antifibrotic in EMBO Molecular Medicine 2023-05-26 06:00
I-Mab Announces Encouraging Phase 1b/2 Study Results of Patients with Advanced NSCLC Receiving Uliledlimab and Toripalimab Combination Therapy at ASCO 2023 2023-05-26 05:01
Invivoscribe Announces Updated Reimbursement for the LeukoStrat CDx FLT3 Mutation Assay to Select Newly Diagnosed FLT3-ITD Positive AML Patients Eligible for VANFLYTA in Japan 2023-05-26 05:00
Hepagene Therapeutics to Present at the European Association for the Study of the Liver (EASL) Congress 2023 2023-05-25 22:00
HanAll Biopharma and Daewoong Pharmaceutical Enter into Co-Development Agreement with NurrOn Pharmaceuticals to Develop Therapy for Parkinson's Disease 2023-05-25 19:00
Telix to Host Briefing with U.S. Leadership Team and Key Opinion Leaders to Highlight Innovation in Urology 2023-05-25 19:00
AffaMed Therapeutics Announces Partner Allgenesis Reports Encouraging Preliminary Safety and Efficacy Data from the AG-73305 Phase 2a Trial for the Treatment of Diabetic Macular Edema 2023-05-25 15:52
111 to Announce First Quarter 2023 Unaudited Financial Results on June 15, 2023 - Conference Call to Follow 2023-05-25 14:05
TYK2/JAK1 Inhibitor AC-201 of Accropeutics Bioscience gained Human Research Ethics Committees (HREC) permission for Phase I 2023-05-25 09:51
Hope for knee osteoarthritis sufferers with advent of global clinical trial. 2023-05-25 09:10
Lynk Pharmaceuticals Announces First Cohort of Psoriatic Patients Dosed with LNK01004 in Phase Ib Clinical Study 2023-05-25 08:00
Avixgen accelerates the progress on new drug pipeline development 2023-05-24 21:00
BioRay Filed IND Application for BRY812, a Novel Antibody Drug Conjugate Targeting LIV-1 2023-05-24 16:14
Allgenesis Announces Encouraging Preliminary Safety and Efficacy Data from the AG-73305 Phase 2a Trial for the Treatment of Diabetic Macular Edema 2023-05-24 10:24
SK bioscience Presents Solution for Equitable Access of Vaccine at Regionalized Vaccine Manufacturing Collaborative of World Economic Forum 2023-05-23 20:00
PharmAbcine Receives IND Approval from the Korean MFDS for Phase I Clinical Trial of Its Novel TIE2 Agonistic Antibody in nAMD 2023-05-23 20:00
Minghui Pharmaceutical Inc. Announces First-in-Human Dose of MHB018A, a Subcutaneous Single-Domain IGF-1R Antibody in Phase 1a Healthy Volunteer Study 2023-05-23 19:00
Antengene Announces Claudin 18.2 Antibody-Drug Conjugate ATG-022 Granted Orphan Drug Designations by the U.S. FDA for the Treatment of Gastric and Pancreatic Cancers 2023-05-23 17:25
HanX Biopharmaceuticals announces HX009 IND approval from FDA 2023-05-22 22:00
CSafe Providing Sustainable Thermal Protection for Vyjuvek Gene Therapy from Krystal Biotech 2023-05-22 21:23
1 102 103 104 105 106 413